drugset / Trial / NCT00637143

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

NCT00637143

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare renal transplant recipients on cyclosporine maintenance therapy vs. those converted to tacrolimus-based immunosuppression with respect to renal outcomes.

Timeline

Start
1999-04
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide Oral
Subject Tacrolimus Small molecule Oral